Literature DB >> 6102473

Assessment in man of SK & F 92657, a novel compound with vasodilator and beta-adrenoceptor blocking activity [proceedings].

A Bell, M J Boyce, W L Burland, D D Underwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6102473

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent.

Authors:  W M Edmonstone; K K Manghani; A J Bell; M McLeod; G J Milton-Thompson; W L Burland
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

2.  Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.

Authors:  T Lüscher; J Havelka; P Greminger; J Tuma; M Täuber; W Siegenthaler; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.

Authors:  J A Steiner; A Clancy; K K Manghani; I M James
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

4.  Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds.

Authors:  H Al-Falahi; P M May; A M Roe; R A Slater; W J Trott; D R Williams
Journal:  Agents Actions       Date:  1984-01

5.  Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.

Authors:  B E Karlberg; R Larsson; K P Ohman; B Norlander; A Wirsen; J Hed; B L Lundh; A Flock
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.

Authors:  M Maury; A Berdeaux; A Kher; P Duhaze; J F Giudicelli
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.